Dermatology clinical trials recruiting in New York

8 recruiting dermatology trials match in New York. Showing 8.

• Guselkumab vs Golimumab in PsA TNF Inadequate Responder PatientsRecruiting

  Phase 3 · University of Pennsylvania · New York, New York

• Targeted Investigation of Microbiome 2 Treat Atopic Dermatitis (TIME-2)Recruiting

  Phase 1 · National Institute of Allergy and Infectious Diseases (NIAID) · New York, New York

• A Study of Upadacitinib in Adult Participants With Moderate-to-Severe Atopic Dermatitis and Inadequate Response to DupilumabRecruiting

  Phase 3 · AbbVie · New York, New York

• A Study to Evaluate the Efficacy and Safety of Subcutaneous Amlitelimab on Background Topical Corticosteroids Therapy in Participants Aged 12 Years and Older With Moderate-to-severe AD Who Have Had an Inadequate Response to Prior Biologic Therapy or an Oral JAK InhibitorRecruiting

  Phase 3 · Sanofi · New York, New York

• A Real World Study to Globally Assess Disease Burden in Adolescent and Adult Participants With Alopecia Areata, Vitiligo, or Hidradenitis SuppurativaRecruiting

  N/A · AbbVie · Ciudad Autonoma de Buenos Aire, Buenos Aires

• Pharmacokinetics, Safety, and Efficacy of Povorcitinib in Adolescent Participants With Moderate to Severe Hidradenitis SuppurativaRecruiting

  Phase 2 · Incyte Corporation · Phoenix, Arizona

• Observational Study of Pediatric Rheumatic Diseases: The CARRA RegistryRecruiting

  N/A · Duke University · Albany, New York

• Long-Term Safety Study of Deucravacitinib Versus Ustekinumab in Participants With Psoriasis (PRAGMATYK)Recruiting

  Phase 3 · Bristol-Myers Squibb · Kew Gardens, New York

Source: ClinicalTrials.gov. Recruitment status changes often — confirm on each study page.